GameSpot may receive revenue from affiliate and advertising partnerships for sharing this content and from purchases through links. The Nintendo Switch 2 is reportedly launching in June, with a ...

A newly found chain-reaction phase change in 2D MoTe2 lowers energy barriers, enabling faster control of electronic and ...

Fast-growing mortgage lender selects nCino to support dozens of branch brands across 49 states while enhancing the borrower experience ...

Crimson Desert is in development for Switch 2, with basic gameplay already running. Pearl Abyss's shareholder briefing had a ...

Louisiana’s colleges and universities are bringing home hundreds of millions for construction projects and other key ...

Quick Review The EcoFlow DELTA 3 Ultra Plus is a powerful portable power station built for homeowners who want reliable emergency backup without committing to a permanent whole-home battery ...

INTENT Biologics, a clinical-stage biotechnology company developing first-in-class exosome-based biologic therapies for serious conditions with significant unmet medical need, announced today that the ...

Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today positive results from the Phase III Krascendo 1 study evaluating divarasib, an investigational next-generation KRAS ...

Novo Nordisk advances post‑Wegovy strategy with stronger obesity, diabetes data Novo Nordisk touts real‑world and late‑stage results for CagriSema and Zenagamtide at ADA 2026 ...

Seacoast United’s 14U Girls Academy team will travel to Richmond, Virginia to compete in the National Finals for the first ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how the drug works.

World’s first anti-ageing gene therapy trial begins as ER-100 is injected into a human eye, testing partial cellular reprogramming to restore vision and fight ageing ...